Radiopharm Theranostics Ltd ADR (RADX)

$16.19 +10.59 (189.11%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 10,245
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; a...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9824 5254
Fax: 61 3 9822 7735
Address:
62 Lygon Street, Level 3, Carlton, Australia
RadioIsotope25
RadioIsotope25 Dec. 5 at 3:33 AM
$CAPR Looks like the same guys that were short CAPR are getting margin calls and bought in on their shorts in $INMB that was shkreli’s short play a few months ago. As I recall he tweeted INMB was only worth 50 cents. Not sure why investors bet against biotechs worn shorts considering the upside is gigantic on good data. I think Radiopharm Theranostics has that CAPR upside with their product mix and the backing of the giant $LNTH $INMB $RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Dec. 4 at 3:05 PM
$RADX Worth $350 million to a billion. I think Lantheus will take plunge on completion of RAD101 trial. Lantheus avg bite size $300-350
0 · Reply
biospeculator
biospeculator Dec. 4 at 2:01 PM
$RADX Blah Blah Blah KISS The company has a robust pipeline in the early stages which will cost money to progress that they don't have. Welcome to biotech. In order to sell the company, they need to advance the pipeline with money they don't have. So why start more trials when capital is scarce? The recent raise showed no appetite from retail when the stock was diluted and down. Simple. RAD101. Every successful phase II radio diagnostic in the space due to derisking has been bought for an average of 250M upfront and up to an additional 750M in residuals. INMO RADX knows the needed capital will be available mid 2026 upon the sale of RAD101. GLTA
1 · Reply
Lalalilala
Lalalilala Dec. 4 at 12:28 PM
$RADX Which resolutions were voted on and adopted? According to the official minutes published after the meeting of December 3, 2025: Resolution 1: Ratification of the previously issued First Tranche Placement Shares. Resolution 2: Approval of the issuance of a Second Tranche Placement Share. Resolution 3: Approval of the issuance of Placement Attaching Options. Resolution 4: Approval of the issuance of Share Purchase Plan Attaching Options. All these resolutions were adopted by formal vote, with large majorities: votes in favor far exceeded votes against and abstentions.
1 · Reply
PaulWalter
PaulWalter Dec. 4 at 10:01 AM
$RADX Still here. Anyone know their up to date cash position? Thanks.
0 · Reply
RadioIsotope25
RadioIsotope25 Dec. 4 at 4:04 AM
Terbium-161 vs Lutetium-177: Comparing Next-Gen Radioligands for Prostate Cancer - Michael Hofman $RADX https://www.urotoday.com/video-lectures/mcrpc-treatment/video/mediaitem/4909-terbium-161-vs-lutetium-177-comparing-next-gen-radioligands-for-prostate-cancer-michael-hofman.html
1 · Reply
Lalalilala
Lalalilala Dec. 3 at 9:14 PM
$RADX However, the NBI index argues in our favor. 🤔
0 · Reply
Peligroso
Peligroso Dec. 3 at 8:43 PM
$RADX https://clinicaltrials.gov/study/NCT07259213
0 · Reply
e17
e17 Dec. 3 at 8:14 PM
$RADX Really high compression as we move into a bullish divergence. Lets see if we get a nice slingshot here. 👀
0 · Reply
RadioIsotope25
RadioIsotope25 Dec. 3 at 8:12 PM
$RADX When this starts going up it won’t be easy to watch for shorts.
0 · Reply
Latest News on RADX
No data available.
RadioIsotope25
RadioIsotope25 Dec. 5 at 3:33 AM
$CAPR Looks like the same guys that were short CAPR are getting margin calls and bought in on their shorts in $INMB that was shkreli’s short play a few months ago. As I recall he tweeted INMB was only worth 50 cents. Not sure why investors bet against biotechs worn shorts considering the upside is gigantic on good data. I think Radiopharm Theranostics has that CAPR upside with their product mix and the backing of the giant $LNTH $INMB $RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Dec. 4 at 3:05 PM
$RADX Worth $350 million to a billion. I think Lantheus will take plunge on completion of RAD101 trial. Lantheus avg bite size $300-350
0 · Reply
biospeculator
biospeculator Dec. 4 at 2:01 PM
$RADX Blah Blah Blah KISS The company has a robust pipeline in the early stages which will cost money to progress that they don't have. Welcome to biotech. In order to sell the company, they need to advance the pipeline with money they don't have. So why start more trials when capital is scarce? The recent raise showed no appetite from retail when the stock was diluted and down. Simple. RAD101. Every successful phase II radio diagnostic in the space due to derisking has been bought for an average of 250M upfront and up to an additional 750M in residuals. INMO RADX knows the needed capital will be available mid 2026 upon the sale of RAD101. GLTA
1 · Reply
Lalalilala
Lalalilala Dec. 4 at 12:28 PM
$RADX Which resolutions were voted on and adopted? According to the official minutes published after the meeting of December 3, 2025: Resolution 1: Ratification of the previously issued First Tranche Placement Shares. Resolution 2: Approval of the issuance of a Second Tranche Placement Share. Resolution 3: Approval of the issuance of Placement Attaching Options. Resolution 4: Approval of the issuance of Share Purchase Plan Attaching Options. All these resolutions were adopted by formal vote, with large majorities: votes in favor far exceeded votes against and abstentions.
1 · Reply
PaulWalter
PaulWalter Dec. 4 at 10:01 AM
$RADX Still here. Anyone know their up to date cash position? Thanks.
0 · Reply
RadioIsotope25
RadioIsotope25 Dec. 4 at 4:04 AM
Terbium-161 vs Lutetium-177: Comparing Next-Gen Radioligands for Prostate Cancer - Michael Hofman $RADX https://www.urotoday.com/video-lectures/mcrpc-treatment/video/mediaitem/4909-terbium-161-vs-lutetium-177-comparing-next-gen-radioligands-for-prostate-cancer-michael-hofman.html
1 · Reply
Lalalilala
Lalalilala Dec. 3 at 9:14 PM
$RADX However, the NBI index argues in our favor. 🤔
0 · Reply
Peligroso
Peligroso Dec. 3 at 8:43 PM
$RADX https://clinicaltrials.gov/study/NCT07259213
0 · Reply
e17
e17 Dec. 3 at 8:14 PM
$RADX Really high compression as we move into a bullish divergence. Lets see if we get a nice slingshot here. 👀
0 · Reply
RadioIsotope25
RadioIsotope25 Dec. 3 at 8:12 PM
$RADX When this starts going up it won’t be easy to watch for shorts.
0 · Reply
Lalalilala
Lalalilala Dec. 3 at 5:54 PM
$RADX Is there anyone who can read financial statements who can tell me how many shares make up RADX's market capitalization in the US market? My trading platform can't even tell me anymore. 9,270,000 is the last known figure I can find... but I know there are many more than that now.
1 · Reply
Lalalilala
Lalalilala Dec. 3 at 5:28 PM
$RADX This isn't the picture I was expecting to see today, lol! Our social situation is still nonexistent, and all we see are sales figures. Our day will come...
0 · Reply
RadioIsotope25
RadioIsotope25 Dec. 3 at 2:37 PM
$CAPR Biotech shorts are getting slaughtered today.. Thank God $RADX
1 · Reply
RadioIsotope25
RadioIsotope25 Dec. 3 at 1:06 PM
$RADX We are due for good news
1 · Reply
RadioIsotope25
RadioIsotope25 Dec. 3 at 12:30 PM
$RADX It’s good only 3.88 million share dilution at $6 per share. Retail round failed only $240K usd raised.
1 · Reply
Lalalilala
Lalalilala Dec. 3 at 9:42 AM
$RADX
1 · Reply
Lalalilala
Lalalilala Dec. 3 at 9:23 AM
$RADX RADX: fell 9.23% to close at $4.23, with relatively low trading volume of 43,666 shares. The recent completion of the share purchase plan could influence future price movements.
0 · Reply
RadioIsotope25
RadioIsotope25 Dec. 2 at 11:29 PM
$RADX Her2 data slated on website for this month
0 · Reply
RadioIsotope25
RadioIsotope25 Dec. 2 at 11:16 PM
$RADX All biotechs were down today. No news here.
0 · Reply
RadioIsotope25
RadioIsotope25 Dec. 2 at 8:37 PM
$RADX
0 · Reply
RadioIsotope25
RadioIsotope25 Dec. 2 at 8:35 PM
$RADX Somebody stealing shares
0 · Reply
Manpreet00
Manpreet00 Dec. 2 at 8:33 PM
$RADX damn I feel jealous of ppl who get to load up on these levels.
0 · Reply